-
Experimental Drug Slows Worsening Effects of Alzheimer's
Eli Lilly and Co. said Wednesday its experimental Alzheimer’s drug appeared to slow worsening of the mind-robbing disease in a large study. NBC 5’s Bianca Castro talked with Frisco neurologist Dr. Aimee Garza about how it works.
-
Attend the Forget Me Not Gala
Learn how you can attend the Aging Mind Foundation’s Forget Me Not Gala. It’s a fundraiser helping to find a cure for Alzheimer’s. MORE: AgingMindFoundation.org
-
Gala Raises Awareness About Alzheimer's and Dementia in the Black Community
The upcoming Event to Remember gala hopes to raise awareness, diagnosis and treatment of Alzheimer’s among Black Americans. The woman chairing the event, Melonie Carnegie, hopes her story will resonate with others.
-
Experimental Drug Shows Signs of Slowing Cognitive Decline in Alzheimer's Patients, Study Finds
New data shows an experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening. The next question is how much difference that might make in people’s lives.
-
Spreading Awareness of Alzheimer's Disease
We sit down with the author of Love Remembers, Kathe Ambrose Goodwin, to learn more about her family’s journey of being affected by Alzheimer’s Disease. MORE: Amazon.com
-
Couple's RV Stolen Before Taking Dream Trip
A Plano couple married for nearly 60 years was planning a dream ride – a series of final trips in a renovated RV. Now police are asking for the public’s help finding the camper. Allie Spillyards explains what’s at stake.
-
Couple's RV Stolen as They Prepare for Final Road Trips Amid Alzheimer's Battle
After his wife was diagnosed with Alzheimer’s, Nick Druga purchased and renovated ‘Joyce’s Dream’ to make a few more memories together.
-
UNTHSC Receives $150M Grant to Unlock the Keys to Alzheimer's Disease
North Texas is about to be home to one of the largest ever studies into Alzheimer’s disease. The National Institutes of Health just awarded $150 million to the UNT Health Science Center in Fort Worth.
-
New Treatment Uses Stimulation to Target Alzheimer's
There’s a new treatment sparking discussion that could slow or halt the progression of Alzheimer’s disease.
-
Can Your Eyes Predict Alzheimer's?
When it comes to Alzheimer’s disease, the earlier the diagnosis the better and soon, maybe your eye doctor will be able to diagnose Alzheimer’s disease earlier than ever before.
-
A Window into Your Brain: Can Your Eyes Predict Alzheimer's?
When it comes to Alzheimer’s disease, the earlier the diagnosis the better, and soon, maybe your eye doctor will be able to diagnose Alzheimer’s disease earlier than ever before.
-
OL Masterminds IPA to Fund Alzheimer's Research
Duke Manyweather, who is the creator of the organization OL Masterminds, has teamed up with Grapevine-based Hop & Sting Brewery to launch an IPA with proceeds donated to help fund Alzheimer’s research.
-
OL Masterminds Owner Partners with DFW Brewery to Fund Alzheimer's Research
Duke Manyweather, of OL Masterminds, is partnering with Grapevine-based Hop & Sting Brewery to launch an IPA with proceeds going to help fund Alzheimer’s research.
-
Medicare Weighs Premium Cut After Limiting Alzheimer's Drug
Medicare says it’s considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer’s drug projected to drive up program costs
-
New Drug Trial Underway for Moderate Alzheimer's Disease
Researchers are testing an investigational drug for people with mild to moderate Alzheimer’s disease.
-
Investigational Drug Trial Underway for Moderate Alzheimer's Disease
Researchers are testing an investigational drug for people with mild to moderate Alzheimer’s disease.
-
Medicare Limits Coverage of $28,000-A-Year Alzheimer's Drug
Medicare says it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned
-
Medicare Told to Reassess Premium Hike for Alzheimer's Drug
U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of seniors this year
-
Why Biogen's Alzheimer's Drug Aduhelm Is So Controversial
Biogen’s Alzheimer’s drug Aduhelm was heralded as a historic triumph against the memory-robbing disease. Now, the company is trying to keep it afloat.